drugset / Trial / NCT01165476

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

NCT01165476

Phase 1 Completed 64 enrolled United Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the bioavailability of a single 1mg dose of treprostinil diethanolamine sustained release (SR) tablets manufactured by two independent facilities.

Timeline

Start
2010-07
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil diethanolamine Unknown 1 mg Oral